Literature DB >> 21452070

How radical should surgery be for early esophageal cancer?

Dean Bogoevski1, Maximilian Bockhorn, Alexandra Koenig, Matthias Reeh, Katharina von Loga, Guido Sauter, Thomas Rösch, Jakob R Izbicki.   

Abstract

BACKGROUND: We have compared the oncologic effectiveness of limited resection (LR) techniques such as transhiatal (TH) or limited resection of the esophagogastric junction with intestinal interposition (LREGJ) in the treatment of early esophageal carcinoma with that of the extended resection such as the classical thoracoabdominal (TA) en bloc esophagectomy.
METHODS: We performed a retrospective analysis of prospectively collected data of 113 patients with T1 esophageal cancer (57 adeno- and 56 squamous cell carcinomas) who had surgical resection with systematic lymphadenectomy. Forty-one underwent extensive (TA) and 72 limited resection (51 TH and 21 LREGJ).
RESULTS: Complete resection (R0) was achieved in all cases. Lymphatic metastases were seen in none of the mucosal but in 26.8% of the submucosal T1 cancers. The median lymph node yield was significantly higher in patients with extensive resection (24 vs. 15 lymph nodes; p=0.036), but this did not affect the overall survival (median=88 vs. 102 months, 5-year survival probability=57.8 vs. 67.7%; log rank=0.578). The median hospital stay and ICU stay were significantly shorter in the LR group (p=0.039 and p = 0.044, respectively).
CONCLUSION: Limited resection leads to lower lymph node yield but similar oncologic effectiveness as the extensive surgery. It may represent a valuable alternative in the treatment of patients with early (submucosal) esophageal carcinoma.

Entities:  

Mesh:

Year:  2011        PMID: 21452070     DOI: 10.1007/s00268-011-1069-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  44 in total

Review 1.  Surgical treatment of dysplasia and adenocarcinoma.

Authors:  T R DeMeester
Journal:  Gastroenterol Clin North Am       Date:  1997-09       Impact factor: 3.806

2.  Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.

Authors:  Val J Lowe; Fargol Booya; J G Fletcher; Mark Nathan; Eric Jensen; Brian Mullan; Eric Rohren; Maurits J Wiersema; Enrique Vazquez-Sequeiros; Joseph A Murray; Mark S Allen; Michael J Levy; Jonathan E Clain
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

3.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

4.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

5.  Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma.

Authors:  T Lerut; P Nafteux; J Moons; W Coosemans; G Decker; P De Leyn; D Van Raemdonck; N Ectors
Journal:  Ann Surg       Date:  2004-12       Impact factor: 12.969

6.  Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.

Authors:  Andrew P Barbour; Nabil P Rizk; Mithat Gonen; Laura Tang; Manjit S Bains; Valerie W Rusch; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

7.  Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients.

Authors:  J J Gondrie; R E Pouw; C M T Sondermeijer; F P Peters; W L Curvers; W D Rosmolen; K K Krishnadath; F Ten Kate; P Fockens; J J Bergman
Journal:  Endoscopy       Date:  2008-05       Impact factor: 10.093

Review 8.  Treatment results of adenocarcinoma of the gastroesophageal junction.

Authors:  Yutaka Yonemura; Noriaki Kojima; Taiichi Kawamura; Gorou Tsukiyama; Etsurou Bandou; Naoko Sakamoto; Yasuhiro Tsubosa; Hiroshi Sato
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

Review 9.  Multiple management modalities in esophageal cancer: epidemiology, presentation and progression, work-up, and surgical approaches.

Authors:  Mary Koshy; Natia Esiashvilli; Jerome C Landry; Charles R Thomas; Richard H Matthews
Journal:  Oncologist       Date:  2004

10.  The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction.

Authors:  Wilko I Staiger; Ulrich Ronellenfitsch; Georg Kaehler; Hans Ulrich Schildhaus; Antonia Dimitrakopoulou-Strauss; Matthias Hm Schwarzbach; Peter Hohenberger
Journal:  World J Surg Oncol       Date:  2008-04-04       Impact factor: 2.754

View more
  6 in total

Review 1.  The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.

Authors:  Kerry B Dunbar; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2012-06       Impact factor: 10.864

2.  Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus.

Authors:  Michael F Nentwich; Katharina von Loga; Matthias Reeh; Faik G Uzunoglu; Andreas Marx; Jakob R Izbicki; Dean Bogoevski
Journal:  J Gastrointest Surg       Date:  2013-10-04       Impact factor: 3.452

Review 3.  Surgery of esophageal cancer.

Authors:  F G Uzunoglu; M Reeh; A Kutup; J R Izbicki
Journal:  Langenbecks Arch Surg       Date:  2013-01-25       Impact factor: 3.445

4.  Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy.

Authors:  Joyce Wong; Jill Weber; Khaldoun Almhanna; Sarah Hoffe; Ravi Shridhar; Richard Karl; Kenneth L Meredith
Journal:  J Gastrointest Surg       Date:  2013-07-02       Impact factor: 3.452

5.  Comparison of three digestive tract reconstruction methods for the treatment of Siewert II and III adenocarcinoma of esophagogastric junction: a prospective, randomized controlled study.

Authors:  Zhiguo Li; Jianhong Dong; Qingxing Huang; Wanhong Zhang; Kai Tao
Journal:  World J Surg Oncol       Date:  2019-12-06       Impact factor: 2.754

6.  TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?

Authors:  Felipe Monge Vieira; Marcio Fernandes Chedid; Richard Ricachenevsky Gurski; Carlos Cauduro Schirmer; Leandro Totti Cavazzola; Ricardo Vitiello Schramm; André Ricardo Pereira Rosa; Cleber Dario Pinto Kruel
Journal:  Arq Bras Cir Dig       Date:  2021-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.